In a lipopolysaccharide (LPS)-induced ALI model in mice, PF-573228 preserves EC barrier function by inhibiting FAK phosphorylation at Y397, highlighting its therapeutic potential for the treatment of mouse ALI [111]. Here, PTK2 is linked to acute respiratory distress syndrome.